Jurgen Bommer
Overview
Explore the profile of Jurgen Bommer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
1471
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fissell R, Karaboyas A, Bieber B, Sen A, Li Y, Lopes A, et al.
Hemodial Int
. 2015 May;
20(1):38-49.
PMID: 25975222
Because of multiple comorbidities, hemodialysis (HD) patients are prescribed many oral medications, including phosphate binders (PBs), often resulting in a high "pill burden." Using data from the international Dialysis Outcomes...
2.
Hecking M, Karaboyas A, Rayner H, Saran R, Sen A, Inaba M, et al.
Am J Hypertens
. 2014 Mar;
27(9):1160-9.
PMID: 24651636
Background: Diffusive sodium removal has been recommended to control hypertension in hemodialysis patients. Recent evidence on hospitalizations and mortality, however, challenged the benefit of lower dialysate sodium prescriptions and ignited...
3.
Kleophas W, Karaboyas A, Li Y, Bommer J, Reichel H, Walter A, et al.
Kidney Int
. 2013 Nov;
84(5):1051-2.
PMID: 24172742
No abstract available.
4.
Lopes A, Tong L, Thumma J, Li Y, Fuller D, Morgenstern H, et al.
Am J Kidney Dis
. 2012 Mar;
60(1):90-101.
PMID: 22385781
Background: Poor nutritional status and both hyper- and hypophosphatemia are associated with increased mortality in maintenance hemodialysis (HD) patients. We assessed associations of phosphate binder prescription with survival and indicators...
5.
Hafner V, Czock D, Burhenne J, Riedel K, Bommer J, Mikus G, et al.
Antimicrob Agents Chemother
. 2010 Apr;
54(6):2596-602.
PMID: 20368400
Sulfobutylether-beta-cyclodextrin (SBECD), a large cyclic oligosaccharide that is used to solubilize voriconazole (VRC) for intravenous administration, is eliminated mainly by renal excretion. The pharmacokinetics of SBECD and voriconazole in patients...
6.
Ritz E, Bommer J
Clin J Am Soc Nephrol
. 2009 Dec;
4 Suppl 1:S71-8.
PMID: 19996009
High cardiovascular mortality is the major cause of reduced life expectancy of patients who are on hemodialysis. Classical risk factors cannot fully explain the magnitude of the risk. This article...
7.
Tentori F, Blayney M, Albert J, Gillespie B, Kerr P, Bommer J, et al.
Am J Kidney Dis
. 2008 Jun;
52(3):519-30.
PMID: 18514987
Background: Abnormalities in serum calcium, phosphorus, and parathyroid hormone (PTH) concentrations are common in patients with chronic kidney disease and have been associated with increased morbidity and mortality. No clinical...
8.
Heinrich T, Heidt H, Hafner V, Schmidt-Gayk H, Jenetzky E, Walter-Sack I, et al.
Nephrol Dial Transplant
. 2008 Apr;
23(9):2861-7.
PMID: 18388122
Background: Under steady-state conditions urinary calcium (Ca) excretion corresponds to the Ca load in healthy subjects. However, in chronic haemodialysis patients reliable data on Ca load are not available. In...
9.
Brancaccio D, Bommer J, Coyne D
Drugs
. 2007 Sep;
67(14):1981-98.
PMID: 17883283
Secondary hyperparathyroidism (SHPT) is a common and serious consequence of chronic kidney disease (CKD). SHPT is a complex condition characterised by a decline in 1,25-dihydroxyvitamin D and consequent vitamin D...
10.
Port F, Pisoni R, Bommer J, Locatelli F, Jadoul M, Eknoyan G, et al.
Clin J Am Soc Nephrol
. 2007 Aug;
1(2):246-55.
PMID: 17699213
The international Dialysis Outcomes and Practice Patterns Study (DOPPS) is well suited to evaluate levels of deviation from emerging and established guidelines to clinical practice of hemodialysis, over time and...